These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17186593)

  • 1. Evaluating disease management. DMAA's new guidelines assess healthcare outcomes.
    Lubell J
    Mod Healthc; 2006 Dec; 36(48):20. PubMed ID: 17186593
    [No Abstract]   [Full Text] [Related]  

  • 2. Numbers that count. Disease-management industry is taking steps to deliver more reliability, consistency in data on program outcomes.
    Benko LB
    Mod Healthc; 2007 Jan; 37(3):30-2. PubMed ID: 18444287
    [No Abstract]   [Full Text] [Related]  

  • 3. Testing the DMAA's recommendations for disease management program evaluation.
    Serxner S; Mattke S; Zakowski S; Gold D
    Popul Health Manag; 2008 Oct; 11(5):241-5. PubMed ID: 18942915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization guidelines for disease management programs.
    Fetterolf DE
    Manag Care Interface; 2007 Jan; 20(1):15. PubMed ID: 17310648
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors affecting the success of disease management.
    Eichert JH; Patterson RB
    J Oncol Manag; 1998; 7(1):15-8. PubMed ID: 10179004
    [No Abstract]   [Full Text] [Related]  

  • 6. Process versus outcomes: what is acceptable evidence of success in developing disease state management programs?
    Kozma CM
    Med Interface; 1996 Nov; 9(11):75-6. PubMed ID: 10162563
    [No Abstract]   [Full Text] [Related]  

  • 7. Physicians take lead in the integration of medication and disease management.
    Med Manag Netw; 1999 Jun; 7(6):1-7. PubMed ID: 10537669
    [No Abstract]   [Full Text] [Related]  

  • 8. Random fluctuations and validity in measuring disease management effectiveness for small populations.
    Farah JR; Kamali K; Harner J; Duncan IG; Messer TC
    Popul Health Manag; 2008 Dec; 11(6):307-16. PubMed ID: 19108646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease management: its place in wound care.
    Salcido R
    Adv Wound Care; 1999 Apr; 12(3):104-5. PubMed ID: 10655790
    [No Abstract]   [Full Text] [Related]  

  • 10. Pioneering Medicaid DM program produces robust outcomes.
    Dis Manag Advis; 2006 Jun; 12(6):61-3. PubMed ID: 17803176
    [No Abstract]   [Full Text] [Related]  

  • 11. The American Academy of Nursing's guidelines for healthcare quality and outcomes: implications for pediatric nursing practice.
    American Academy of Nursing
    J Spec Pediatr Nurs; 2005; 10(3):99-102. PubMed ID: 16083428
    [No Abstract]   [Full Text] [Related]  

  • 12. How a heart failure home care disease management program makes a difference.
    Rosa MA
    Home Healthc Nurse; 2008 Sep; 26(8):483-90. PubMed ID: 18787489
    [No Abstract]   [Full Text] [Related]  

  • 13. [The German program for disease management guidelines: evaluation by use of quality indicators].
    Kopp IB; Geraedts M; Jäckel WH; Altenhofen L; Thomeczek C; Ollenschläger G
    Med Klin (Munich); 2007 Aug; 102(8):678-82. PubMed ID: 17694287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Western New York Kidney Disease Project shows how disease management can work.
    Schorr W
    Nephrol News Issues; 2003 Aug; 17(9):31-2. PubMed ID: 12971223
    [No Abstract]   [Full Text] [Related]  

  • 15. Proving ROI: experts urge DMOs to run a tighter ship.
    Dis Manag Advis; 2004 Nov; 10(11):121-4. PubMed ID: 15682784
    [No Abstract]   [Full Text] [Related]  

  • 16. Guidelines for pharmacoeconomic and outcomes research fellowship training programs: joint guidelines from the american college of clinical pharmacy and the international society of pharmacoeconomics and outcomes research.
    Kane-Gill S; Reddy P; Gupta SR; Bakst AW
    Pharmacotherapy; 2008 Dec; 28(12):1552. PubMed ID: 19025439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of chronic disease management on outcomes and cost of care for Medicaid beneficiaries.
    Zhang NJ; Wan TT; Rossiter LF; Murawski MM; Patel UB
    Health Policy; 2008 May; 86(2-3):345-54. PubMed ID: 18207282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Company introduces standards for disease management programs.
    Qual Lett Healthc Lead; 2000 Mar; 12(3):14-5, 1. PubMed ID: 10947528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has the CMS rule of "4 visits per month" influenced patient outcomes? Nephrology healthcare providers should determine the frequency of patient visits.
    Larson K
    Nephrol Nurs J; 2007; 34(3):343-4. PubMed ID: 17647305
    [No Abstract]   [Full Text] [Related]  

  • 20. An evaluation of Washington's Medicaid disease-management program.
    Lind A; Kaplan L
    Manag Care Interface; 2007 Oct; 20(10):45-50. PubMed ID: 18405208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.